The Top Line cover image

AbbVie, ADCs and the future of cancer care

The Top Line

00:00

Advancing Cancer Treatment with ADCs

This chapter discusses the insights from the recent ASCO conference on the transformative role of antibody-drug conjugates (ADCs) in cancer therapy. It highlights their potential to replace traditional chemotherapy while exploring advancements in immunotherapy and targeted treatments aimed at enhancing T cell activity within tumors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app